Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Soltes-Rak
E. Soltes-Rak
Gastroenterology
Taxane
Bevacizumab
Debulking
Pathology
3
Papers
54
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preliminary results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
2016
Journal of Clinical Oncology
Peter G. Rose
Richard D. Drake
Patricia S. Braly
Maria C. Bell
Robert M. Wenham
J.H. Hines
A. Alvarez-Secord
E. Soltes-Rak
B. H. Childs
Thomas J. Herzog
Show All
Source
Cite
Save
Citations (19)
Preliminary safety and efficacy results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
2007
Journal of Clinical Oncology
Thomas J. Herzog
Nick M. Spirtos
Jeffrey F. Hines
Patricia S. Braly
Maria C. Bell
Angeles Alvarez Secord
Peter G. Rose
Bradley J. Monk
E. Soltes-Rak
B. H. Childs
Show All
Source
Cite
Save
Citations (2)
Effect of promoter modification on mosquitocidal cryIVB gene expression in Synechococcus sp. strain PCC 7942.
1993
Applied and Environmental Microbiology
E. Soltes-Rak
Donn J. Kushner
D. Dudley Williams
John R. Coleman
Show All
Source
Cite
Save
Citations (33)
1